Search results for "MCI"

showing 10 items of 228 documents

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E a…

2009

Background:Two parallel randomized phase 2 trialswere performed to choose the optimal way of combining cetuximab with gemcitabine in the first-line treatment of elderly (CALC1-E) and adult PS2 (CALC1-PS2) patients with advanced NSCLC. Methods: Stage IV or IIIB NSCLC patients, aged ≥70 years with PS 0–2 for CALC1-E or aged <70 with PS2 for CALC1-PS2, not selected for EGFR expression,were eligible. Patients were randomized to concomitant (gemcitabine, for a maximum of 6 cycles, plus cetuximab until progression) or sequential (gemcitabine, for a maximum of 6 cycles, followed by cetuximab) strategy. A selection design, with 1-year survival rate as the primary endpoint, was applied, requiring 58…

Pulmonary and Respiratory MedicineOncologyAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsAdolescentSettore MED/06 - Oncologia MedicaCetuximabNSCLCAntibodies Monoclonal HumanizedDeoxycytidinelaw.inventionYoung AdultRandomized controlled triallawInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancerPS2 patientSurvival analysisAgedCetuximabbusiness.industryCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryClinical trialTreatment OutcomeOncologyConcomitantPatient ComplianceFemalebusinessElderly patientmedicine.drug
researchProduct

Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.

2014

BACKGROUND: Colorectal cancer is the third most commonly diagnosed cancer worldwide, with up to 25% of patients presenting with metastases at the time of diagnosis. Despite pulmonary metastasectomy many patients go on to develop pulmonary recurrence, which might be linked to the presence of lung micrometastases. In this setting, the adjuvant administration of high-dose chemotherapy by isolated lung perfusion (ILP) has shown encouraging results. However, the tolerance to and efficacy of modern gemcitabine (GEM)-based chemotherapy regimens during adjuvant ILP remain unknown. We conducted a dose-escalating preclinical study to evaluate the immediate and delayed toxicity of GEM in a pig model t…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAntimetabolites AntineoplasticLung Neoplasmsendocrine system diseasesPulmonary toxicityIsolated lung perfusionmedicine.medical_treatmentAcute Lung InjurySus scrofaDrug Evaluation PreclinicalAnesthesia GeneralGastroenterologyDeoxycytidineInternal medicinemedicineAnimalsLungChemotherapyLungDose-Response Relationship Drugbusiness.industryGeneral MedicineChemotherapy regimenGemcitabineGemcitabineDisease Models Animalmedicine.anatomical_structureAnesthesiaChemotherapy Cancer Regional PerfusionToxicityAcute DiseaseSurgeryFemaleMetastasectomyCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake amo…

2016

Background WHO recommends a male circumcision (MC) prevalence rate higher than 80% to have a substantial impact on the HIV-AIDS epidemic in Eastern and Southern Africa. Orange Farm, a township in South Africa, has a free-for-service voluntary medical male circumcision (VMMC) clinic in operation since 2008. Following an intense campaign from 2008 to 2010, MC prevalence rate increased to 55.4% (ANRS-12126). Ongoing and past VMMC campaigns focused on youths, through school talks, and adults at a community level. The main objective of the study was to assess the change in MC prevalence rate among adults aged 18–19 and 18–49 years in the past 5 years. Methods A cross-sectional survey (ANRS-12285…

RNA virusesMaleCross-sectional studyEpidemiologyPrevalenceSocial Scienceslcsh:MedicineHIV InfectionsOrange (colour)Pathology and Laboratory MedicineGeographical locationsCultural AnthropologySouth Africa0302 clinical medicineImmunodeficiency VirusesSociologyEnvironmental protectionCircumcisionMedicine and Health SciencesPrevalenceMedicine030212 general & internal medicineYoung adultReproductive System Procedureslcsh:ScienceMultidisciplinarySchoolsMiddle Aged3. Good healthReligionMale circumcisionMedical MicrobiologyHIV epidemiologyViral PathogensVirusesInfectious diseasesPathogens0305 other medical scienceDemand creationResearch ArticleAdultAdolescentSurgical and Invasive Medical ProceduresViral diseasesMicrobiologyEducation03 medical and health sciencesYoung AdultRetrovirusesAdultsHumansSex organMicrobial Pathogens030505 public healthbusiness.industryLentiviruslcsh:ROrganismsBiology and Life SciencesHIVPatient Acceptance of Health CareCross-Sectional StudiesCircumcision MaleTurnoverAge GroupsAnthropologyPeople and PlacesAfricaPopulation Groupingslcsh:Qbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

The use of triamcinolone combined with surgery in major ear keloid treatment: a personal two stages approach

2015

Background: Keloid is a fibroproliferative disorder characterized by an abnormal deposition of collagen within a wound. Despite an increased understanding of wound healing and collagen metabolism, the exact cause, the clinical behavior, and gold standard of treatment for keloids remain an enigma. There is no one right way of treatment, the results are variable, and the management of ear keloids can be difficult and frustrating both for patients and physicians. Traditional techniques include intralesional steroids, topical applications of silicone, vitamins, and segmental excision by lasers or surgery. The purposes of this article are to review the literature concerning the current therapies…

Reconstructive surgerymedicine.medical_specialtyTriamcinolone acetonidebusiness.industryGold standardEvidence-based medicinemedicine.diseaseDermatologySurgeryEar keloidPlastic surgeryKeloidQuality of lifeTriamcinolone acetonide injectionMedicineSurgeryRadical excisionskin and connective tissue diseasesbusinessWound healingmedicine.drug
researchProduct

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

2016

Background: Trimodality bladder preservation therapy (BPT) in muscle invasive bladder cancer (MIBC) includes a maximal transurethral resection followed by concurrent chemoradiotherapy as an alternative to radical cystectomy (RC) in appropriately selected patients, or as a treatment option in non-cystectomy candidates. Several chemotherapy regimens can be used in BPT, but little is known about current practice patterns. Objective: To describe utilization patterns of BPT and associated survival outcomes in MIBC. Methods: Data were collected from the Retrospective International Study of Cancers of the Urothelial Tract (RISC), a database of 3,024 consecutive patients from 29 international acade…

Research ReportOncologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologychemoradiotherapyCystectomy03 medical and health scienceschemistry.chemical_compoundTransitional cell carcinomacystectomy0302 clinical medicineInternal medicinemedicineBladder cancerPerformance statusbusiness.industrymedicine.diseaseCarboplatinGemcitabine3. Good healthRegimenTransitional cell carcinomaOncologychemistrycomparative effectiveness research030220 oncology & carcinogenesisbusinessChemoradiotherapymedicine.drugBladder Cancer
researchProduct

NEONAX trial: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer, a phase II study of the AI…

2019

4128 Background: Survival in pancreatic cancer (PDAC) is still poor even after curatively intended resection. Perioperative treatment approaches improve outcome in various tumor entities. Data on perioperative treatment in resectable PDAC are limited and there is a debate whether neoadjuvant treatment might impair subsequent surgery by adding perioperative morbidity or mortality. Methods: NEONAX is a randomized phase II study (planned 166 patients) of perioperative gemcitabine/nab-paclitaxel (Arm A: 2 pre- and 4 post-operative cycles, Arm B: 6 cycles adjuvant) for patients with primarily resectable PDAC. Primary objective is DFS at 18 months after randomization. Secondary objectives are 3-…

Resectable Pancreatic CancerOncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPhases of clinical researchPerioperativeInterim analysismedicine.diseaseGemcitabine3. Good health03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinePancreatic cancermedicinebusinessAdjuvant030215 immunologymedicine.drugNab-paclitaxelJournal of Clinical Oncology
researchProduct

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gef…

2019

Management of multiple primary cancers, a not so infrequent event in oncology practice, is a critical issue due to the lack of literature . In this study, we reported the case of a patient with metachronous double metastatic non small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) who received gefitinib in combination with gemcitabine plus nab-paclitaxel and with mFOLFOX6 in first and second line, respectively. She achieved a progression free survival and an overall survival (OS) of 28 months for NSCLC and PFS-1 and OS of 20 and 13 months, respectively for PDAC. Moreover, the combination of gefitinib and chemotherapies treatments displayed a good safety profile. Given …

Second-line therapyChemotherapyPancreatic ductal adenocarcinomabusiness.industrymedicine.medical_treatmentLong Term Survivormedicine.diseaseGemcitabineGefitinibCancer researchmedicineLung cancerbusinessoncology_oncogenicsmedicine.drugNab-paclitaxel
researchProduct

Circumcision and Sexually Transmitted Disease Prevention: Evidence and Reticence

2017

Circumcision is one of the oldest surgical procedures and the most common surgical procedure performed on males. It is practiced for three main reasons: ritual or religious meanings, prophylactic hygienic purposes, and therapeutic indications. Male circumcision is advocated as an efficacious prevention strategy against sexually transmitted diseases. One of the main biological mechanisms responsible for the lower human immunodeficiency virus (HIV) infection rate in heterosexual circumcised men is the protective effect of keratinization of the glans. Moreover, male circumcision removes the inner part of the prepuce containing Langerhans cells that are targeted by HIV. Several observational st…

Sexually transmitted diseasemedicine.medical_specialtySettore MED/43 - Medicina Legalebusiness.industryCircumcision HIV sexually transmitted diseases sexual function ethicsFamily medicinemedicinebusinessSettore MED/24 - Urologia
researchProduct

Intravesical gemcitabine in superficial bladder tumors. Results of a phase I-II study

2004

the good tolerability of intravesical gemcitabine have been recently published. The evaluation of the activity on a papillary marker lesion is the best tool to measure the efficacy of a drug by intravesical route against superficial transitional cell carcinoma of the bladder (TCCB). The scientific background and the ethical acceptability of this approach have been validated by the European Organization for Research and Treatment of Cancer Urological Group. The aim of the present study was to evaluate the ablative efficacy of weekly intravesical instillations of gemcitabine against a histologically proven papillary marker lesion. MATERIAL & METHODS: Twenty-seven patients, affected by recurre…

Sperfial bladder cancer intravesical chemotherapy marker lesion gemcitabineSettore MED/24 - Urologia
researchProduct

Low density lipoproteins and human serum albumin as the carriers of squalenoylated drugs: insights from molecular simulations

2018

We have studied the interaction of three clinically promising squalenoylated drugs (gemcitabine-squalene, adenine-squalene, and doxorubicin-squalene) with low-density lipoproteins (LDL) by means of atomistic molecular dynamics simulations. It is shown that all studied squalenoylated drugs accumulate inside the LDL particles. This effect is promoted by the squalene moiety, which acts as an anchor and drives the hydrophilic drugs into the hydrophobic core of the LDL lipid droplet. Our data suggest that LDL particles could be a universal carriers of squalenoylated drugs in the bloodstream. Interaction of gemcitabine-squalene with human serum albumin (HSA) was also studied by ensemble of dockin…

Squalene[PHYS.PHYS.PHYS-BIO-PH]Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Drug CompoundingPharmaceutical ScienceSerum Albumin Human02 engineering and technologyPlasma protein bindingMolecular Dynamics Simulation010402 general chemistry01 natural sciencesMolecular Docking SimulationDeoxycytidineSqualenechemistry.chemical_compound[ PHYS.PHYS.PHYS-BIO-PH ] Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Lipid dropletDrug DiscoverymedicineMoietyHumansComputingMilieux_MISCELLANEOUSDrug CarriersBinding SitesAdenine[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnologyHuman serum albuminGemcitabine3. Good health0104 chemical sciences[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryLipoproteins LDLMolecular Docking Simulation[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical scienceschemistryDocking (molecular)Doxorubicin[ CHIM.THEO ] Chemical Sciences/Theoretical and/or physical chemistryBiophysicsMolecular MedicineNanoparticles0210 nano-technologyDrug carrierHydrophobic and Hydrophilic Interactionsmedicine.drugProtein Binding
researchProduct